Chronic Spontaneous Urticaria After New Coronavirus Infection: Clinical Cases
Background. Inefficacy of conventional chronic spontaneous urticaria (CSU) treatments significantly reduces patients’ quality of life. Data on CSU (triggered by new coronavirus infection) prevalence and course in children is very limited.Clinical case description. Authors have presented three clinic...
Saved in:
| Main Authors: | Aset Kh. Ibisheva, Madina R. Shakhgireeva, Linda V.-M. Dzhabrailova, Asya B. Khildikharoeva, Linda S. Uspanova, Kamila A.-R. Getaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2024-12-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020-08-01) -
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
by: Riccardo Asero, et al.
Published: (2024-11-01) -
Omalizumab treatment can increase the serum levels of vitamin D in patients with chronic spontaneous urticaria
by: MENG Zhen, et al.
Published: (2025-03-01) -
Potential markers of response to treatment of patients with chronic spontaneous urticaria
by: N. O. Pereverzina, et al.
Published: (2021-06-01) -
Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
by: Petek Üstün, et al.
Published: (2025-07-01)